SMC’s Bone Joint Center has built a multidisciplinary treatment system that draws on talent from the departments of orthopedic surgery, rheumatology, and rehabilitation medicine to tackle musculoskeletal diseases and musculoskeletal involvement of systemic diseases. Our staff includes 12 professors who each have a huge amount of clinical experience in their respective fields. With cutting-edge imaging, medical exercise, neurologic testing, and rehabilitation facilities, we strive to provide world-class diagnostic and therapeutic services for musculoskeletal diseases.
Major areas of treatment
Specialties: Osteoarthritis, inflammatory arthritis (rheumatoid arthritis), sports injury, ligamentous injury, fracture, dislocation, musculoskeletal infection, musculoskeletal tumor, avascular necrosis, musculoskeletal congenital anomaly and acquired deformation, peripheral nerve disease
Our center is the premier venue for primary and secondary total hip and knee replacement in Korea. We have also developed, researched, and applied Cartistem, a regenerative stem cell agent for arthritis. We have optimized treatment for patients with arthritis by integrating different departments and implementing standardized treatment as well as pre- and post-operative rehabilitation.
The Bone Joint Center diagnoses patients early and accurately to improve medical outcomes and reduce recovery time:
- Simple X-rays
- Magnetic resonance imaging (MRI)
- Computerized tomography (CT)
- Whole body bone scan
- Positron emission tomography (PET)
- Nerve conduction study and electromyogram
- Sports medicine tests
Latest treatment methods
- Artificial joint replacement
- Joint regeneration treatment (stem cell arthritis regeneration treatment)
- Arthroscopic surgery
- Sports rehabilitation
- Intra-articular injection
- Extracorporeal shock wave therapy
- Robotic artificial joint replacement surgery
- Osteotomy and artificial joint replacement surgery using navigation
Recent trends in clinical research
By fostering cooperation between industry, academia, and public research, we are improving how we perform artificial joint replacement and implantation. We are also developing next-generation stem cell-based arthritis regeneration agents (adult stem cell and cord blood stem cell), three-dimensional arthroscopy cameras, and robot surgical devices, as well as establishing a system to predict postoperative functional recovery using big data analysis.